Family Pharmacy Recalls Lorazepam Infusion Due to Sterility Risk
Family Pharmacy of Statesville recalls Lot 07312020@6 Lorazepam 1 mg/mL bags due to lack of sterility assurance. Check your prescription.
Stop using this now
Lack of Assurance of Sterility
Contact the company
What happened, in plain English
Family Pharmacy of Statesville is recalling one bag of Lorazepam 1 mg/mL Infusion Solution because it lacks assurance of sterility. The affected item is Lot #07312020@6 with a Beyond Use Date (BUD) of 8/7/2020. This recall was issued on August 6, 2020, and the product was distributed only in North Carolina. Read more at govinfonow.com/recall/36851-family-pharmacy-recalls-lorazepam-infusion-due-to-sterility-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/36851-family-pharmacy-recalls-lorazepam-infusion-due-to-sterility-risk · Updated October 11, 2026 · FDA enforcement record: FDA #D-0665-2022
Cite this page
“Family Pharmacy Recalls Lorazepam Infusion Due to Sterility Risk.” GovInfoNow, updated October 11, 2026. https://govinfonow.com/recall/36851-family-pharmacy-recalls-lorazepam-infusion-due-to-sterility-risk. Based on FDA recall #D-0665-2022 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0665-2022%22&limit=1).
Why it’s dangerous
The product lacks assurance of sterility, meaning it may contain harmful microorganisms. Administering a non-sterile infusion solution can lead to serious infections or other complications in patients.
Who’s affected
Patients in North Carolina who received Lorazepam infusion solution from Family Pharmacy of Statesville between the manufacturing date and the recall date. Individuals with this specific lot number are at risk of infection due to potential non-sterility.
How to tell if you have this one
Check your prescription for Lorazepam 1 mg/mL Infusion Solution in 250 mL bags. Look specifically for Lot #07312020@6 and a Beyond Use Date (BUD) of 8/7/2020. The product was sold by Family Pharmacy of Statesville.
- Brand
Family Pharmacy of Statesville- Category
Drug
All 12 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
- Classification
Class II- Status
Terminated- Distribution
NC only
| Recall number | Product, codes & lots | Quantity |
|---|---|---|
| D-0656-2022 | Hydromorphone HCl 2 mg/mL Infusion 250 mL bags, Rx only, Family Pharmacy of Statesville, Inc.; Lot #: 07212020@4 BUD: 10/19/2020; 07212020@4 BUD: 10/30/2020 | 2 bags |
| D-0657-2022 | Hydromorphone HCl 1 mg/mL 250 mL bags, Rx only, Family Pharmacy of Statesville, Inc.; Lot #: 07272020@2 BUD: 10/25/2020; 07302020@1 BUD: 10/28/2020; 08012020@1 BUD: 10/30/2020 | 4 bags |
| D-0658-2022 | Hydromorphone HCl 5 mg/mL Infusion in 250 mL bags, Rx only, Family Pharmacy of Statesville, Inc.; Lot #: 07292020@7 BUD: 8/12/2020 | 1 bag |
| D-0659-2022 | Hydromorphone HCl 0.1 mg/mL Infusion in 1000 mL bags, Rx only, Family Pharmacy of Statesville, Inc.; Lot #: 08022020@1 BUD: 8/17/2020 | 1 bag |
| D-0660-2022 | Trimix (Alprostadil/Papaverine/Phentolamine) 20 mcg/30 mg/0.5 mg Injectable 5 mL vials, Rx only, Family Pharmacy of Statesville, Inc.; Lot #: 07212020@ BUD: 9/4/2020 | 2 vials |
| D-0661-2022 | Trimix (Alprostadil/Papaverine/Phentolamine) 10 mcg/20 mg/1 mg Injectable 5 mL vials, Rx only, Family Pharmacy of Statesville, Inc.; Lot #:07232020@1 BUD: 9/6/2020; 07282020@1 BUD: 9/11/2020; 07282020@2 BUD: 9/11/2020 | 5 vials |
| D-0662-2022 | Vancomycin14 mg/mL Fortified Ophthalmic Solution in 5 mL bottles, Rx only, Family Pharmacy of Statesville, Inc.; Lot: 07312020@2 BUD: 9/14/2020 | 3 bottles |
| D-0663-2022 | Morphine Sulfate 6 mg/mL Infusion in 250 mL bag, Rx only, Family Pharmacy of Statesville, Inc.; Lot #: 07212020@3 BUD: 10/19/2020; 07292020@2 BUD: 10/27/2020 | 8 bags |
| D-0664-2022 | Ketamine 50 mg Infusion (LV 1) Solution in 250 mL bags, Rx only, Family Pharmacy of Statesville, Inc.; Lot #: 07212020@1 BUD: 8/4/2020; 07232020@2 BUD: 8/6/2020; 07302020@2 BUD: 8/13/2020 | 3 bags |
| D-0665-2022 | Lorazepam 1 mg/mL Infusion Solution in 250 mL bags, Rx only, Family Pharmacy of Statesville, Inc.; Lot #: 07312020@6 BUD: 8/7/2020 | 1 bag |
| D-0666-2022 | Methylcobalamin 1 mg/mL Injectable in 1 mL syringes, Rx only, Family Pharmacy of Statesville, Inc.; Lot #: 07282020@3 BUD: 8/11/2020 | 5 syringes |
| D-0667-2022 | Fentanyl 150 mcg/mL Infusion Solution in 250 mL bags, Rx only, Family Pharmacy of Statesville, Inc.; Lot #: 07312020@5 BUD: 8/14/2020 | 1 bag |
What to do — step by step
Stop using the medication
Do not use the Lorazepam infusion solution if it matches the recalled lot number and BUD.
Contact your pharmacy
Reach out to Family Pharmacy of Statesville for instructions on returning or disposing of the product.
Where it went and when
Where it was distributed
Distributed in North Carolina.
FDA distribution: “NC only” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: North Carolina.
Recall timeline
FDA terminated this recall 3 years after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0665-2022 (August 6, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0665-2022 to see it in context.
- Plain-language summary written by qwen3.6:35b-a3b on October 11, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.